Trans-cranial Doppler predicts early neurologic deterioration in anterior circulation ischemic stroke after successful endovascular treatment

0
0
0

Trans-cranial Doppler predicts early neurologic deterioration in anterior circulation ischemic stroke after successful endovascular treatment

Acute ischemic stroke is a leading cause of long-term disability worldwide, and endovascular treatment (EVT)—using tools like stent retrievers to clear blocked brain arteries—has transformed care for patients with large vessel occlusions in the anterior circulation (major arteries supplying the front of the brain). But even when EVT successfully reopens a blocked artery, up to 1 in 5 patients experience early neurologic deterioration (END) within 72 hours—a sudden worsening of symptoms that can derail recovery. Now, a 2020 study from researchers at Capital Medical University in Beijing and the University at Buffalo offers a breakthrough: a simple, non-invasive test called transcranial Doppler (TCD) might predict who’s at risk.

What Is Early Neurologic Deterioration (END)?

END is defined as a ≥4-point increase in the National Institutes of Health Stroke Scale (NIHSS)—a tool doctors use to measure stroke severity—or a ≥1-point increase in the “level of consciousness” category within 72 hours of EVT. It’s a devastating complication: patients with END are 10 times more likely to have a poor outcome (needing help with daily tasks) 3 months later, and their risk of death triples.

The most common causes of END in this study were:

  1. Vasogenic cerebral edema: Swelling from leaky blood vessels in the brain (65% of cases).
  2. Symptomatic intracranial hemorrhage (sICH): Bleeding in the brain that worsens symptoms (24% of cases).
  3. Ischemia progression: The original stroke expanding (11% of cases).

The Study: Can TCD Predict END?

Researchers led by Yan-Bo He (Xuanwu Hospital, Capital Medical University) and Ying-Ying Su (Xuanwu Hospital) set out to see if TCD—an ultrasound test that measures blood flow in the brain’s middle cerebral arteries (MCA)—could spot early signs of END. Here’s what they did:

Who Was Included?

From 2016 to 2018, the team enrolled 112 patients with anterior circulation ischemic stroke (ACIS) (blockages in the internal carotid artery or MCA M1/M2 segments) who underwent EVT. They focused on 80 patients who had successful recanalization—meaning the artery was fully open with less than 50% residual narrowing (confirmed by the Thrombolysis in Cerebral Infarction [TICI] scale, which rates blood flow restoration).

How Was TCD Used?

Within 72 hours of EVT, the team used a portable TCD device to measure blood flow in the MCA (the main artery supplying the front of the brain). Key metrics included:

  • Pulse index (PI): A measure of blood flow resistance (higher PI = higher intracranial pressure).
  • Mean flow velocity (MFV): Average blood flow in the artery.
  • iMFV/MBP: Ratio of ipsilateral MFV (blood flow in the affected artery) to mean blood pressure (MBP)—a sign of whether blood flow is outpacing pressure (hyperperfusion).

Key Findings: TCD Spots High-Risk Patients

Of the 80 patients with successful recanalization:

  • 21% (17 patients) experienced END—most within 24 hours.
  • Two TCD parameters predicted END:
    1. PI ≥0.85: Patients with a PI of 0.85 or higher were 11 times more likely to have END. PI correlates with intracranial pressure—higher PI means the brain is under more pressure (often from swelling or bleeding).
    2. iMFV/MBP ≥0.84: A ratio of 0.84 or higher made patients 9 times more likely to have END. This ratio signals cerebral hyperperfusion—too much blood flow to the brain, which can damage fragile blood vessels and cause edema or hemorrhage.

TCD was especially good at ruling out END: a negative result (PI <0.85 or iMFV/MBP <0.84) meant a 90–91% chance the patient wouldn’t have END (high negative predictive value).

Why This Matters for Stroke Care

EVT is life-saving, but END is a major barrier to recovery. TCD’s value lies in its accessibility:

  • Non-invasive: No needles, radiation, or surgery required.
  • Portable: Can be done at the bedside—critical for stroke patients who can’t move.
  • Real-time: Gives instant results so doctors can act fast.

For clinicians, TCD could be a “crystal ball” to:

  • Monitor high-risk patients: If TCD shows a high PI or iMFV/MBP, doctors can closely watch for edema or hemorrhage and adjust treatments (like lowering blood pressure to prevent hyperperfusion).
  • Personalize care: High-risk patients might need more frequent neurological checks or early imaging (CT/MRI) to catch problems before they worsen.
  • Improve outcomes: Early intervention could reduce END rates and severity.

Limitations to Consider

TCD isn’t perfect:

  • Temporal window requirement: About 5–10% of people don’t have a usable “temporal window” (thin enough bone on the side of the head for ultrasound to pass through).
  • Single-center study: Results need confirmation in larger, multi-center trials.

The Bottom Line

For patients who’ve had successful EVT for anterior circulation stroke, TCD is a simple tool that could mean the difference between a smooth recovery and a sudden setback. As Ying-Ying Su, the study’s corresponding author, notes: “TCD isn’t a replacement for clinical judgment—but it’s a powerful addition to help doctors protect patients after EVT.”

For stroke survivors and their families, this research offers hope: a small ultrasound test could help prevent one of the most devastating complications of EVT and get more patients back on the road to recovery.

Yan-Bo He, Ying-Ying Su, Gary B. Rajah, et al. Trans-cranial Doppler predicts early neurologic deterioration in anterior circulation ischemic stroke after successful endovascular treatment. Chinese Medical Journal. 2020;133(14):1655–1661. doi: doi.org/10.1097/CM9.0000000000000881

Was this helpful?

0 / 0